Código QR (código de barras bidimensional)

Effectiveness and tolerability of eptinezumab in treating patients with migraine resistant to conventional preventive medications and CGRP (receptor) antibodies: a multicentre retrospective real-world analysis from Germany

Abstract Background Eptinezumab is a monoclonal antibody that targets calcitonin gene-related peptide (CGRP mAb) and is used for migraine prophylaxis. Efficacy data are mainly from clinical trials, real-world data are hardly available yet. Reimbursement policy in Germany leads to eptinezumab mainly...

Fuld beskrivelse

Na minha lista:
Principais autores: Armin Scheffler, Pauline Wenzel, Merle Bendig, Astrid Gendolla, Jale Basten, Christoph Kleinschnitz, Michael Nsaka, Diana Lindner, Steffen Naegel, Philipp Burow, Robert Fleischmann, Dagny Holle
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2024-05-01
Serier:The Journal of Headache and Pain
Fag:
Episodic migraine
Chronic migraine
Drug resistant
Antibody switch
Online adgang:https://doi.org/10.1186/s10194-024-01788-1
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker